Chemoinformaics analysis of 22-HYDROXY-DOCOSANOIC-ACID
| Molecular Weight | 356.591 | nRot | 21 |
| Heavy Atom Molecular Weight | 312.239 | nRig | 1 |
| Exact Molecular Weight | 356.329 | nRing | 0 |
| Solubility: LogS | -4.627 | nHRing | 0 |
| Solubility: LogP | 7.844 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 68.4849 |
| nHD | 2 | BPOL | 45.0091 |
| QED | 0.221 |
| Synth | 1.705 |
| Natural Product Likeliness | 0.391 |
| NR-PPAR-gamma | 0.98 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -5.266 |
| MDCK | 0.0000185 |
| BBB | 0.016 |
| PPB | 0.980318 |
| VDSS | 0.806 |
| FU | 0.00798271 |
| CYP1A2-inh | 0.175 |
| CYP1A2-sub | 0.151 |
| CYP2c19-inh | 0.169 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.083 |
| CYP2c9-sub | 0.992 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.027 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.009 |
| CL | 3.063 |
| T12 | 0.452 |
| hERG | 0.108 |
| Ames | 0.004 |
| ROA | 0.011 |
| SkinSen | 0.952 |
| Carcinogencity | 0.045 |
| EI | 0.944 |
| Respiratory | 0.837 |
| NR-Aromatase | 0.203 |
| Antiviral | Yes |
| Prediction | 0.555773 |